These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3690370)

  • 1. Anxiogenic effects in benzodiazepine withdrawal are linked to the development of tolerance.
    File SE; Baldwin HA; Aranko K
    Brain Res Bull; 1987 Nov; 19(5):607-10. PubMed ID: 3690370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiogenic behavior in rats during acute and protracted ethanol withdrawal: reversal by buspirone.
    Lal H; Prather PL; Rezazadeh SM
    Alcohol; 1991; 8(6):467-71. PubMed ID: 1781924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine withdrawal in the elevated plus-maze test in rats.
    Chopin P; Assié MB; Briley M
    Psychopharmacology (Berl); 1993; 110(1-2):19-26. PubMed ID: 7870883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor.
    Baldwin HA; File SE
    Brain Res Bull; 1988 May; 20(5):603-6. PubMed ID: 2838131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal.
    Irvine EE; Cheeta S; File SE
    Pharmacol Biochem Behav; 2001 Feb; 68(2):319-25. PubMed ID: 11267637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze.
    File SE; Mabbutt PS; Hitchcott PK
    Psychopharmacology (Berl); 1990; 102(1):98-101. PubMed ID: 1975449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that the increased anxiety detected in the elevated plus-maze during chlordiazepoxide withdrawal is not due to enhanced noradrenergic activity.
    Baldwin HA; Hitchcott PK; File SE
    Pharmacol Biochem Behav; 1989 Dec; 34(4):931-3. PubMed ID: 2623049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal.
    File SE; Andrews N
    Psychopharmacology (Berl); 1991; 105(4):578-82. PubMed ID: 1771225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats.
    Rudoy CA; Van Bockstaele EJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1119-29. PubMed ID: 17513029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to acute anxiolysis but no withdrawal anxiogenesis in mice treated chronically with 5-HT1A receptor antagonist, WAY 100635.
    Cao BJ; Rodgers RJ
    Neurosci Biobehav Rev; 1998; 23(2):247-57. PubMed ID: 9884117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mianserin in the treatment of ethanol withdrawal in the rat: prevention of behaviors indicative of anxiety.
    Prather PL; Rezazadeh SM; Lal H
    Psychopharmacol Bull; 1991; 27(3):285-9. PubMed ID: 1775600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral measures of anxiety during opiate withdrawal.
    Grasing K; Wang A; Schlussman S
    Behav Brain Res; 1996 Oct; 80(1-2):195-201. PubMed ID: 8905143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity.
    Dawson GR; Crawford SP; Collinson N; Iversen SD; Tricklebank MD
    Psychopharmacology (Berl); 1995 Apr; 118(3):316-23. PubMed ID: 7617825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose- and time-dependent expression of anxiety-like behavior in the elevated plus-maze during withdrawal from acute and repeated intermittent ethanol intoxication in rats.
    Zhang Z; Morse AC; Koob GF; Schulteis G
    Alcohol Clin Exp Res; 2007 Nov; 31(11):1811-9. PubMed ID: 17877783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flumazenil prevents the development of chlordiazepoxide withdrawal in rats tested in the social interaction test of anxiety.
    Baldwin HA; File SE
    Psychopharmacology (Berl); 1989; 97(3):424-6. PubMed ID: 2497494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiogenic action of caffeine: an experimental study in rats.
    Bhattacharya SK; Satyan KS; Chakrabarti A
    J Psychopharmacol; 1997; 11(3):219-24. PubMed ID: 9305413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of afobazole effects on diazepam withdrawal-induced anxiety in rats].
    Eksp Klin Farmakol; 2014; 77(4):6-9. PubMed ID: 25076752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the dependence potential of the selective 5-H1A agonist ipsapirone in rats and of its effects on benzodiazepine withdrawal.
    Goudie AJ; Leathley MJ
    Psychopharmacology (Berl); 1991; 103(4):529-37. PubMed ID: 1676531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
    Prather PL; Rezazadeh SM; Lane JD; Rowan GA; Hooper ML; Lytle DA; Emmett-Oglesby MW; Lal H
    J Pharmacol Exp Ther; 1993 Feb; 264(2):622-30. PubMed ID: 8094750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze test is abolished by previous administration of chlordiazepoxide or buspirone.
    Escarabajal MD; Torres C; Flaherty CF
    Life Sci; 2003 Jul; 73(8):1063-74. PubMed ID: 12818358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.